Winston County Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 15341 Highway 278, Double Springs, AL 35553 Phone: 205-489-3322 Fax: 205-489-3325 |
Capstone Double Springs Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 110 Legion Rd Ste B, Double Springs, AL 35553 Phone: 256-847-4858 Fax: 205-489-2417 |
Winston County Medical Clinic 2 Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 15341 Highway 278, Double Springs, AL 35553 Phone: 205-489-3322 Fax: 205-789-3325 |
News Archive
Sun Pharmaceutical Industries Ltd. today announced that the United States District Court for the Southern District of New York had dismissed in its entirety the complaint filed by Taro Pharmaceutical Industries Ltd. seeking to block the Tender Offer by Sun's subsidiary, Alkaloida Chemical Company Exclusive Group Ltd., to purchase all outstanding Ordinary Shares of Taro.
Medicure Inc. announces that, following a review by the listings committee of the Toronto Stock Exchange (the "TSX"), the common shares of Medicure will be delisted from the TSX effective at the close of trading on February 26, 2010. While the Company will endeavor to meet the continued listing requirements of the TSX prior to the delisting date, the Company also intends to make application for listing of its common shares on the TSX Venture Exchange (the "TSX- V") or NEX to ensure continued and seamless trading liquidity for shareholders.
The ability of HIV to mutate has been a major challenge to vaccine development. As the body produces antibodies to target the outer HIV envelope protein, this protein changes, thwarting the circulating antibodies' ability to neutralize it.
Calestous Juma, an author and professor at Harvard Kennedy School, writes in an East African opinion piece that as South Sudan prepares for independence on July 9, it "is the time" for the country "to chart a new path by defining a new role for its military" by "shift[ing] its military budget to development objectives."
Researchers report encouraging preclinical results as they pursue elusive therapeutic strategies to repair scarred and poorly functioning heart tissues after cardiac injury – describing an experimental molecular treatment for heart failure.
› Verified 2 days ago